Research Facility

Charlottesville, Virginia 22908

1 studies enrolling now · 5 studies all time

What they study most

Appendiceal Cancer, Arrhythmias, Bladder Cancer, Breast Cancer, Chronic Constipation, Colorectal Cancer, Cutaneous T-Cell Lymphoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma (HCC), Melanoma, Merkel Cell Carcinoma, Ovarian Cancer

Studies at this site

• Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC — Recruiting now
• A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies — Completed
• A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers — Completed
• Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs) — Completed
• Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation — Stopped early